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Abstract Enhancement of dissolution characteristics of poorly soluble drug 
Domperidone by solid dispersion technique using modified locust bean gum 
(MLBG) and further conversion into tablet dosage form with fast dissolving 
characteristics is being explored in current study. Solid dispersions (SD) were 
prepared by solvent evaporation technique. F1, F3, F5 and F7 batches of 
SD (1:1, 1:3, 1:5 and 1:7 ratio of drug to MLBG) were prepared. Maximum 
solubility was observed in 1:3 ratio (F3 batch) in comparison to pure drug. 
Fourier Transform Infrared spectroscopy studies revealed no interaction of 
drug to polymer MLBG. Transition from crystalline to amorphous state of 
drug was analyzed by X-RD studies. SEM studies revealed change in surface 
characteristics of drug in solid dispersions. In vitro release studies revealed 
maximum dissolution in F3 (93% in 30 min). Further solid dispersion batches 
F3 was compressed into tablets including other excipients and crosspovidone 
as superdisintegrant. The in vitro release from tablet batch revealed better 
dissolution characteristics (95% in 30 min) in comparison to marketed tablet 
(50% in 60 min). Therefore, MLBG solid dispersion tablets of domperidone 
can be a convenient dosage form with enhanced dissolution characteristics.
Keywords: Solubility, Natural carrier, Dissolution, Solid dispersions, 
Disintegration
1. INTRODUCTION
Recent drug development in pharmaceutical industry emphasizes on use of 






BCS Class II drugs (poor solubility and good permeability). Various techniques 
have been evidenced to enhance the solubility of poorly soluble drugs such 
as micronization, salt formation, liquisolids compacts, complexation with 
polymers, prodrugs, co-precipitation using antisolvent, pH alteration, use of 
surfactants, and solid dispersions. Solid dispersion has been widely employed 
technique to improve the dissolution characteristics of poorly soluble drugs. 
The solid dispersion has been defined as a dispersion of one or more API 
(active pharmaceutical ingredient) in an inert carrier or matrix at the solid 
state prepared by solvent-melting method. Solid dispersion is practically 
simple technique which can overcome the limitations of the above techniques 
(8, 7). Domperidone maleate (DOM), an antiemetic drug, has poor aqueous 
solubility and high permeability (BCS class II drug). It is slightly soluble in 
water (0.0925mg/mL) and has low oral bioavailability (13-17%). It shows 
high protein binding (91-93%) (http://www.drugbank.ca/drugs/DB01184). 
Research reports have mentioned improved solubility of Domperidone by solid 
dispersion technique using different carriers (PVP K30 and Poloxamer 188 
and PEG 6000; sodium alginate etc) (2, 6). Fast dissolving tablets have been 
reported using Domperidone binary and ternary solid dispersions containing 
(Gelucire 44/14 and Gelucire 50/13; Poloxamer 188 and 407; PEG 6000, 4000 
and PVP K30) and also of HP β-CD inclusion complex of Domperidone) (5, 
11). The use of MLBG has now been widespread being a natural carrier with 
a number of poorly soluble drugs for solubility enhancement (Atorvastatin, 
Glibenclamide etc) (4, 9).
Current study employed solid dispersions technique using modified locust 
bean gum for development of fast disintegrating tablets of domperidone.
2. MATERIALS AND METHODS
2.1 Materials
Pure drug Domperidone was kindly gifted by IPZAH Pharmaceuticals Ltd, 
Patiala; Locust Bean Gum was gifted by Lucid Colloids Ltd, Delhi. Other 
chemicals used were of AR grade.
2.2 Methods
2.2.1 Preparation of Solid Dispersions
Solid dispersions of Domperidone (drug substance) were prepared by using 
MLBG via solvent evaporation method. Pure drug and polymer MLBG was 
dissolved/dispersed in ethanol (25 ml) in round bottom flask and dispersions 
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batches (F1, F3, F5 and F7) were prepared in different drug to polymer ratios 
(1:1, 1:3, 1:5 and 1:7). All the formulations were first analyzed for solubility 
studies.
2.2.2 Evaluation of Solid Dispersions
Equilibrium Solubility Studies
The equilibrium solubility of solid dispersions was determined in distilled 
water at 37oC. For each preparation, an equivalent of 10 mg of drug was added 
to 50 ml of distilled water in conical flasks. The flasks were kept in shaking 
incubator for 24 h at 37±0.5oC. Then, the solution was filtered and the filtrate 
was assayed spectrophotometrically at 284nm.
Fourier Transform Infrared Spectroscopy
About 10 mg of the sample was mixed with dried potassium bromide of equal 
weight. The mixture was properly grinded using pestle and mortar. Pellets 
are formed by compressing the mixture by using hydraulic press. Transparent 
pellets formed in this way are scanned. The spectra are scanned over a 
frequency range 4000 – 500 cm-1. Infrared absorption spectra of Domperidone 
(drug substance) and solid dispersion batch F3 was obtained using potassium 
bromide disks, under static air using FTIR spectrophotometer.
Scanning Electron Microscopy (SEM)
Samples of Domperidone (drug substance), best batch of solid dispersions (F3) 
were mounted onto the stubs using double sided adhesive tape and then coated 
with gold palladium alloy (150-200 Ao) using fine coat ion sputter (JEOL, fine 
coat ion sputter, JSM-6100, USA). The samples were subsequently analyzed 
under the scanning electron microscope for external morphology.
X-Ray Diffraction (X-RD)
Powder X-Ray diffraction patterns were traced employing X-ray diffractometer 
(X’PertPro,India) for the samples using Ni filtered Cu (K-α) radiations, a 
voltage of 45 kV, a current of 40 mA. The samples were analyzed over 2θ 
range of 0-50o with scan step size of 0.0170o (2θ) and scan step time 25 s.
2.3 Conversion into Tablet Dosage Form
The best batch of solid dispersion (F3) was compressed into tablets (200mg) 
by adding various excipients (Avicel 112, mannitol, talc and magnesium 
stearate). Crosspovidone (CP) was also added to enhance the disintegration 
characteristics. The tablet formulation batches (with and without CP) were 






2.4 Physicochemical Characterization of Tablets
All the standard tests for tablets (weight variation, friability, hardness and 
disintegration) were done as specified in reference standards. Other tests such 
as water absorption ratio and wetting time were carried out as reported in 
literature.
Wetting Time
Five circular tissue papers of 10cm diameter were placed in a petridish (10cm 
diameter). 10 mL of water containing Eosin, a water soluble dye, was added to 
petridish. A tablet was carefully placed on the surface of the tissue paper. The 
time required for water to reach upper surface of the tablet is noted as wetting 
time (1, 10).
Water Absorption Ratio
 A piece of tissue paper folded twice was placed in a small Petri dish (6mm) 
diameter containing 6 ml of water. A tablet was put on the paper & the time 
required for complete wetting was measured (1, 10). The wetted tablet was then 








 is weight of tablet before water absorption and W
a
 is weight of 
tablet after water absorption.
2.5 In vitro Dissolution Studies
In vitro dissolution of tablet batch T2, various solid dispersions and marketed 
tablet T3 was carried out in 900 mL of 0.1N HCl at 37±0.5oC with the stirrer 
rotation speed of 50 rpm using USP II dissolution apparatus. 5ml aliquots were 
Table 1: Composition of tablet batches.
Ingredients T1(mg) T2(mg)
SD powder(eq. to 10 mg drug)  40  40
Avicel 112 120 110
Mannitol  35  35
Talc   2   2
Magnesium Stearate   3   3
Crosspovidone (CP) –  10






Locust Bean Gum 
by Solid Dispersion 
Technique
5
withdrawn at regular intervals of 5, 15, 30, 45, 60, 120 min and suitably diluted 
and assayed spectrophotometrically at 284 nm. 
3. RESULTS AND DISCUSSION
3.1 Equilibrium Solubility Studies
Equilibrium solubility of Domperidone (drug substance) in distilled water was 
found to be very low i.e. 2.96 (µg/ml). Mixing of drug with MLBG in solid 
dispersions (F1, F3, F5 and F7) leads to increase in solubility of drug which 
may be due to wetting characteristics of MLBG. However the higher ratio 
of polymer MLBG (F5, F7) showed a decrease in the equilibrium solubility. 
MLBG in higher ratio caused increased viscosity of the mixture which hinders 
drug solubilization and thereby dissolution also. The comparative solubility 
data is given in Table 2 and shown in Figure 1.









Figure 1: Equilibrium solubility of pure drug (PD) Domperidone and various 






3.2 Fourier Transform Infrared Spectroscopy (FTIR)
FTIR spectra were traced to establish the presence of different functional 
groups. FTIR spectra of Domperidone and solid dispersion batch F3 is shown 
in Figure 2 and 3. FTIR spectrum of sharp characteristic bands at 3125.18, 
1694, 1486.33, 1382.68 and 1150 cm−1 due to stretching vibration bands 
of C=O, N-H, C-N, and two C-O respectively. The presence of almost all 
characteristic peaks of drug (3025.41, 1690.87, 1462, 1374.86 and 1150.43 
cm−1) in spectra of solid dispersion batch (SD3 batch) indicated no interaction 
of drug with polymer. 
3.3 Scanning Electron Microscopy
Scanning electron micrographs of the Domperidone (drug substance) and solid 
dispersion batch F3 shown in Figure 4a and 4b respectively. The drug appeared 
Figure 2: FTIR spectrum of pure drug domperidone.
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as crystalline particles while porous surfaced particles were observed in solid 
dispersion batch (F3) indicating changes in crystallinity of drug. 
3.4 X-Ray Diffraction
The crystallinity characteristics of Domperidone (drug substance) and polymer 
MLBG was determined by X-ray diffraction studies by comparing some 
characteristic peak heights in the diffraction pattern of the formulations with 
that of pure drug. The X-RD pattern of drug, solid dispersion F3 batch and 
MLBG are shown in overlay diagram (Figure 5). Domperidone showed sharp 
peaks of the diffraction angle of 2θ at 14.32, 15.81, 19.96 and 24.97 with peak 
Figure 4: SEM image of a) pure drug domperidone b) solid dispersion batch 
F3.







intensities of 100, 95.02, 69.04 and 57.00 respectively; and the area of 297.56, 
565.48 and 339.21 respectively. Characteristic peaks of drug with decreased 
intensity were observed in diffraction patterns of solid dispersion batch SD3. 
The X-RDresults revealed partial conversion from crystalline to amorphous 
form of drug in the solid dispersion.
3.5 Conversion into Tablet Dosage Form
Tablets were compressed of solid dispersion batch F3. Two batches of 
tablets containing F3 solid dispersion powder (T1 and T2 with and without 
crosspovidone respectively). T1 tablet batch shows slight chipping during 
compression which was overcome by adding crosspovidone (T2 batch). 
Therefore only T2 batch was further evaluated and further compared with 
marketed tablet (Vomistop, Cipla). Marketed tablet was coded as T3. 
3.6 Physicochemical Characterization of Tablets
T2 tablet batch was evaluated for various standard tests (weight variation, 
hardness, and friability, disintegration, wetting time, water absorption ratio and 
in vitro drug release). The results are depicted in Table 3. % weight variation 
of all tablets was within pharmacopoeial limits (±7.5%). The prepared 
tablets possessed sufficient hardness in the range (between 3-3.5 kg/cm²) as 
indicated by good mechanical strength. The good mechanical resistance is 
shown by friability values below 1% for the tablet batch. The wetting time 
and disintegration time values of less than 1 min were observed in tablet batch 
T2. Water absorption ratio of more than 100% in T2 batch suggested sufficient 
swelling and disintegration of tablet leading to better dissolution characteristics. 
Table 3: Physicochemical parameters of tablet batch T2 and 
marketed tablet.
Parameters Tablet (T2) Marketed tablet (Vomistop) T3
Weight variation (mg) 196.84 198.34
Hardness (kg/cm²) 2.7 ± 0.4 3.5± 0.3
Friability (%) 0.75 ± 0.05 0.54 ± 0.04
Disintegration Time (sec) 26.5 ± 3 165 ±5
Wetting Time (sec) 24 ± 2 172± 6
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Marketed tablet T3 passed all the tests (results were in pharmacopoeial limits 
as for conventional tablets).
3.7 In vitro Dissolution studies
In vitro release from various solid dispersions using MLBG (F1, F3, F5 and 
F7) is shown in Figure 6. Maximum dissolution characteristics were observed 
in SD batch F3 with (70% in 15 min and 100% release in 45min). The results 
were also in confirmation with solubility data. The drug release was decreased 
in F5 and F7 which may be due to the reason that higher ratio of polymer lead 
to viscous mixtures which further hinders the drug dissolution. The improved 
dissolution of solid dispersions may be due to increase in wettability, decrease 
in particle size of drug and reduced crystallinity of drug. The decreased 
viscosity of MLBG led to use of gum in higher ratio in the formulation which 
otherwise may not be possible with LBG. 
The drug release from tablet batch T2 was compared with marketed 
tablet T3 (Figure 7). Tablet batch T2 showed 100% release in 45 min which 
is significantly higher than that of marketed tablet T3 (45% in 60 min).The 
results also revealed that compression into tablet does not significantly affect 
the release characteristics which were comparable with that of F3 solid 
dispersion. The presence of crosspovidone may lead to better disintegration 
and thereby dissolution.








The potential of natural carrier MLBG is being explored for the solubility 
enhancement of Domperidone fast dissolving tablets. The wetting ability of 
MLBG alongwith reduced particle size of the drug in solid dispersionsled 
to improved dissolution of drug. The improved dissolution characteristics of 
solid dispersion powder of drug in fast dissolving tablets further results in 
enhanced bioavailability of drug in comparison to that of pure Domperidone 
fast dispersible tablets.
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